Search Results 281-290 of 5643 for albumin

  1. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Patient must have adequate nutritional status with Body Mass Index (BMI) > 18 kg/m^2 and body weight of > 40 kg with serum albumin > 3 g/dL. Baseline ...

  2. Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) - Mayo Clinic

    Another kidney biopsy will not be required as part of the study. Candidates must have failed or be intolerant of prior therapy for their kidney disease. The ...

  3. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

    Albumin ≥ 2.5mg/dL;; Creatinine ≤ 1.5 X upper limit of normal (ULN). NOTE: measured or calculated (per institutional standard) creatinine clearance is ...

  4. Trial Using Keytruda as Initial Therapy in the Treatment of Advanced Mycosis Fungoides - Mayo Clinic

    Albumin > 2.5 mg/dL;; Serum creatinine ≤ 1.5 x upper limit of normal (ULN) OR Measured or calculated creatinine clearance ≥ 60 ml/min for subject with ...

  5. FT516 in Subjects With Advanced Hematologic Malignancies - Mayo Clinic

    Known allergy to the following FT516 components: albumin (human) or DMSO. Presence of any medical or psycho-social issues that are likely to interfere with ...

  6. Study to Evaluate CCS1477 in Haematological Malignancies - Mayo Clinic

    Serum albumin > 2.5 g/dL. Exclusion Criteria: Any investigational agent, chemotherapy, immunotherapy or anticancer agents from a previous clinical study ...

  7. Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer - Mayo Clinic

    - Serum albumin >= 30 g/L (3.0 g/dL) (obtained =< 28 days prior to randomization) - For subjects not receiving therapeutic anticoagulation: international ...

  8. A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity - Mayo Clinic

    Albumin > 2.5 mg/dL. Written, voluntary informed consent. Fertile men and women of childbearing potential must agree to use an effective method of birth ...

  9. Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG - Mayo Clinic

    Synthetic liver dysfunction (albumin deficiency < 2.8 mmol/L) at screening; or 4. Diagnosis of liver fibrosis (Fibroscan > 7 kPa) confirmed by liver ...

  10. Mayo Clinic

    ... . IMG-20457598. Home; cc-mobile-stem-cell-research_mobile. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in ...